These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

974 related articles for article (PubMed ID: 32936058)

  • 61. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
    Modaresi F; Talachian K
    Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Potential applications of marijuana and cannabinoids in medicine].
    Zdrojewicz Z; Pypno D; Cabała K; Bugaj B; Waracki M
    Pol Merkur Lekarski; 2014 Oct; 37(220):248-52. PubMed ID: 25518584
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Re-branding cannabis: the next generation of chronic pain medicine?
    Carter GT; Javaher SP; Nguyen MH; Garret S; Carlini BH
    Pain Manag; 2015; 5(1):13-21. PubMed ID: 25537695
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
    Kruger DJ; Kruger JS
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
    [No Abstract]   [Full Text] [Related]  

  • 65. Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.
    Babalonis S; Walsh SL
    Eur Neuropsychopharmacol; 2020 Jul; 36():206-216. PubMed ID: 32273144
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabinoids: Friend or foe?
    Le Foll B; Tyndale RF
    Clin Pharmacol Ther; 2015 Jun; 97(6):528-31. PubMed ID: 25801347
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Smetana GW; Tetrault JM; Hill KP; Burns RB
    Ann Intern Med; 2021 Feb; 174(2):237-246. PubMed ID: 33556279
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Medical cannabis use in oncology and associated outcomes: A scoping review.
    Valente AC; Lopes LPN; Matheus ME
    J Oncol Pharm Pract; 2024 Jun; 30(4):737-751. PubMed ID: 38477532
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cannabis-based medicines for chronic pain management: current and future prospects.
    Sharon H; Brill S
    Curr Opin Anaesthesiol; 2019 Oct; 32(5):623-628. PubMed ID: 31356363
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cannabis-Based Products for Chronic Pain : A Systematic Review.
    McDonagh MS; Morasco BJ; Wagner J; Ahmed AY; Fu R; Kansagara D; Chou R
    Ann Intern Med; 2022 Aug; 175(8):1143-1153. PubMed ID: 35667066
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cannabis in Pain Treatment: Clinical and Research Considerations.
    Savage SR; Romero-Sandoval A; Schatman M; Wallace M; Fanciullo G; McCarberg B; Ware M
    J Pain; 2016 Jun; 17(6):654-68. PubMed ID: 26961090
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia.
    Berger AA; Keefe J; Winnick A; Gilbert E; Eskander JP; Yazdi C; Kaye AD; Viswanath O; Urits I
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):617-631. PubMed ID: 33004171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
    Boychuk DG; Goddard G; Mauro G; Orellana MF
    J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The therapeutic potential of cannabis and cannabinoids.
    Grotenhermen F; Müller-Vahl K
    Dtsch Arztebl Int; 2012 Jul; 109(29-30):495-501. PubMed ID: 23008748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis.
    Goldenberg M; Reid MW; IsHak WW; Danovitch I
    Drug Alcohol Depend; 2017 May; 174():80-90. PubMed ID: 28319753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Place of Cannabinoids in the Treatment of Gynecological Pain.
    Sinclair J; Abbott J; Proudfoot A; Armour M
    Drugs; 2023 Nov; 83(17):1571-1579. PubMed ID: 37831340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.
    Botsford SL; Yang S; George TP
    Am J Addict; 2020 Jan; 29(1):9-26. PubMed ID: 31577377
    [TBL] [Abstract][Full Text] [Related]  

  • 79. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.
    Haroutounian S; Arendt-Nielsen L; Belton J; Blyth FM; Degenhardt L; Di Forti M; Eccleston C; Finn DP; Finnerup NB; Fisher E; Fogarty AE; Gilron I; Hohmann AG; Kalso E; Krane E; Mohiuddin M; Moore RA; Rowbotham M; Soliman N; Wallace M; Zinboonyahgoon N; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S117-S124. PubMed ID: 34138827
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.
    Rabgay K; Waranuch N; Chaiyakunapruk N; Sawangjit R; Ingkaninan K; Dilokthornsakul P
    J Am Pharm Assoc (2003); 2020; 60(1):225-234.e6. PubMed ID: 31495691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.